CRISPR Therapeutics AG (CRSP) Times Interest Earned (2015 - 2026)
CRISPR Therapeutics AG (CRSP) reported Times Interest Earned of -$8.96 for Q1 2026, up 99.28% sequentially from -$1245.8 in Q3 2025.
CRISPR Therapeutics AG (CRSP) Times Interest Earned (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 12 years of Times Interest Earned data on file, last reported at -$8.96 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned changed N/A year-over-year to -$8.96; the trailing twelve-month figure through Mar 2026 stood at -$44.49 (up 80.7% YoY), and the FY2025 full-year result was -$15.72, up 2.45% from the prior year.
- Times Interest Earned improved to -$8.96 in Q1 2026, from -$1245.8 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.31 in Q4 2023 to a low of -$1245.8 in Q3 2025.
- A 5-year average of -$158.65 and a median of -$10.09 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned soared 107.47% in 2023 and tumbled 2454.49% in 2024, its largest moves.
- Tracing CRSP's Times Interest Earned over 5 years: stood at -$4.09 in 2022, then soared by 107.47% to $0.31 in 2023, then slumped by 1603.74% to -$4.6 in 2024, then plunged by 27001.08% to -$1245.8 in 2025, then soared by 99.28% to -$8.96 in 2026.
- Business Quant data shows CRSP's Times Interest Earned at -$8.96 in Q1 2026, -$1245.8 in Q3 2025, and -$482.79 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | -8.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.96 |
| Sep 30, 2025 | -1,245.84 |
| Jun 30, 2025 | -482.79 |
| Dec 31, 2024 | -4.60 |
| Sep 30, 2024 | -478.83 |
| Jun 30, 2024 | -42.83 |
| Mar 31, 2024 | -49.54 |
| Dec 31, 2023 | 0.31 |
| Sep 30, 2023 | -18.74 |
| Jun 30, 2023 | -10.09 |
| Mar 31, 2023 | -6.08 |
| Dec 31, 2022 | -4.09 |
| Sep 30, 2022 | -8.25 |
| Jun 30, 2022 | -9.05 |
| Mar 31, 2022 | -10.41 |
| Dec 31, 2021 | -0.66 |
| Sep 30, 2021 | -134.78 |
| Jun 30, 2021 | 990.41 |
| Mar 31, 2021 | -207.51 |
| Dec 31, 2020 | -0.12 |